Companies: 10,795·Total market cap: $144.5T
Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc.

STOKNASDAQHealthcare● Active
$29.00
$-1.01(-3.37%)
Market Cap$1.8B
P/E Ratio
52W High$40.22
52W Low$10.635
Overview

Stoke Therapeutics, Inc. (STOK) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · STOK · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-2.83stok eps ttm · stok earnings per shareEarnings history
PE Ratio (TTM)stok pe ratio ttm · stok price to earningsPE Ratio deep dive
Revenue (TTM)$32.1Mstok revenue ttm · stok annual revenueFull revenue history
Dividend YieldNo Dividenddoes stok pay dividends · stok dividend yieldDividend history
Shares Outstanding59.2Mstok shares outstanding · stok floatShares outstanding history
Next EarningsAug 11, 2026Est.stok earnings date · stok next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$184.4M▲ +404.50% YoY
202320242025
stoke therapeutics, inc. revenue · stok revenue 2025
FY 2025Net Income-$6.9M▲ +92.26% YoY
202320242025
stoke therapeutics, inc. net income · stok profit 2025
FY 2025EPS$-0.12▲ +92.73% YoY
202320242025
stok eps · stoke therapeutics, inc. earnings per share 2025
TTM:Revenue: $32.1MNet Income: -$169.8MEPS: $-2.83View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy15 analystsis stok a buy · stok analyst rating
Strong Buy
0
Buy
12
Hold
3
Sell
0
Strong Sell
0
12-Month Price Target
$35.00Low
$29.00Current
$43.86Avg Target51.24% upside
$60.00High
stok price target · stok 12 month forecast

Total: 15 · Buy rate: 80.0%

The STOK analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $43.86, representing +51.24% upside from the current price of $29.00.

Stock Performance

Full History
1D-3.00%
1W-0.51%
1M-11.49%
3M-17.95%
YTD-8.29%
1Y+161.55%
5Y-27.89%

About Stoke Therapeutics, Inc.

CEOIan F. Smith
IPO DateJun 19, 2019
Employees128
CountryUS

Stoke Therapeutics, Inc. is an emerging biopharmaceutical company dedicated to developing innovative antisense oligonucleotide (ASO) therapies. Its primary focus is to target and address the fundament…

what is stoke therapeutics, inc. · stok stock overview · stoke therapeutics, inc. company profile · who is stoke therapeutics, inc. ceo · stok NASDAQ · stoke therapeutics, inc. headquarters · stoke therapeutics, inc. business segments

About Stock Overview & Key Data

Stoke Therapeutics, Inc. (STOK) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 19, 2019. As of the latest trading session, STOK stock price is $29.00, with a market capitalization of $1.8B. The stock has returned +161.55% over the past 12 months and -8.29% year-to-date.

According to 15 Wall Street analysts, the consensus rating for Stoke Therapeutics, Inc. stock is Buy, with an average 12-month price target of $43.86. In fiscal year 2025, Stoke Therapeutics, Inc. reported revenue of $184.4M and net income of -$6.9M. For detailed data — including Stoke Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Stoke Therapeutics, Inc. (STOK) stock price is $29.00. The stock is traded on NASDAQ under the ticker symbol STOK. The 52-week range is $10.63 – $40.22.

STOK stock priceSTOK quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice